Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

74 Results

Guidelines and Advice

Systemic therapy for the treatment of adult patients with lower-risk myelodysplastic syndromes

Status: In-Review
ID: 6-13

Mar 2018

Guidelines and Advice

Safe Administration of Systemic Cancer Therapy Part 2: Administration of Systemic Treatment and Management of Preventable Adverse Events

Status: In-Review
ID: 12-12-2
Version: 2

Nov 2018

Guidelines and Advice

Endorsement of the 2018 American Society of Clinical Oncology Treatment of Malignant Pleural Mesothelioma Guideline

Status: In-Review
ID: 7-14
Version: 3

Dec 2018

Guidelines and Advice

Safety Considerations for the Implementation of Subcutaneous Rituximab Formulation

Status: Current
Version: 1

Jun 2018

Guidelines and Advice

The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement

Status: Current
ID: GL END 2-31

Jul 2018

Guidelines and Advice

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Status: In-Review
ID: GL-END 3-21

Jan 2018

Drug

dexamethasone

Quick Link(s):

Patient Info Sheet

Jan 2018

Drug

prednisone

Quick Link(s):

Patient Info Sheet

Jan 2018

Guidelines and Advice

The Management of Head and Neck Cancer in Ontario

Status: Archived
ID: 5-3

Dec 2009

Guidelines and Advice

Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

Status: Current

Apr 2018

Cancer facts

Women with breast cancer are being appropriately assigned surgical wait times

Feb 2018

Statistical Reports

Ontario Cancer Statistics 2018

Jan 2018

Pages